Skip to main content

Navigation group

Type at least 3 characters
130 articles

Articles

Original Research

Published on 04 Jan 2024

Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial

in Therapy in Gastroenterology

  • Silvia Cruchet
  • Sandra Hirsch
  • Diana Villa-López
  • Mucio Moreno-Portillo
  • Juan C. Palomo
  • Ana T. Abreu-Abreu
  • Juan M. Abdo-Francis
  • Carlos Jiménez-Gutiérrez
  • Martin Rojano
  • Gabriel López-Velázquez
Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1296048
  • 5,930 views
  • 1 citation